Offizieller TitelMaintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer: a randomized double-blinded placebo-controlled multi-center phase III Trial (ENGOT-ov54/Swiss-GO-2/MATAO) including LOGOS (Low Grade Ovarian cancer Sub-study) Kurztitel/Sponsor/StartMATAO Sponsor: Swiss GO trial Group, University Hospital Basel- Womens Hospital, Department of gyneclogy & Gynecologic Oncology, Spitalstr 21, 4031 Basel February 2021 KontaktLocal PI: Prof Andrea Wicki, Stv. Gyn Dr. med. Julian Metzler Tel. +41 43 253 82 91 |